Literature DB >> 3115484

Human immunodeficiency virus and drug misuse: the Edinburgh experience.

R P Brettle1, K Bisset, S Burns, J Davidson, S J Davidson, J M Gray, J M Inglis, J S Lees, J Mok.   

Abstract

During 1985 many drug abusers who lived in Edinburgh were found to be infected with the human immunodeficiency virus (HIV). As a result an alternative counselling and screening clinic for testing for antibodies to HIV was established for use by drug abusers. Four hundred and forty one patients were counselled in the first year, and over 60% were either drug abusers or their sexual contacts. One hundred and fourteen (26%) patients were positive for HIV antibody, and 100 (88%) of these were current or former drug abusers. The HIV seropositivity rate in drug abusers was 52% but was only 7% in their sexual contacts. Services were provided for these people as well as counselling before and after the test. The cost of this counselling service for the first year was 27,000 pounds or 61.22 pounds per patient. The unexpected mobility of 23% of the Edinburgh drug abusers, particularly to other areas of Britain, suggests that similar services need to be set up elsewhere.

Entities:  

Mesh:

Year:  1987        PMID: 3115484      PMCID: PMC1247280          DOI: 10.1136/bmj.295.6595.421

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

Authors:  J R Robertson; A B Bucknall; P D Welsby; J J Roberts; J M Inglis; J F Peutherer; R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

2.  Epidemic of AIDS related virus infection among intravenous drug abusers.

Authors:  R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

3.  The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.

Authors:  N Levy; J R Carlson; S Hinrichs; N Lerche; M Schenker; M B Gardner
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

4.  Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York.

Authors:  T J Spira; D C Des Jarlais; M Marmor; S Yancovitz; S Friedman; J Garber; H Cohen; C Cabradilla; V C Kalyanaraman
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

5.  HTLV-III antibodies in an Edinburgh clinic.

Authors:  R P Brettle; J Davidson; S J Davidson; J M Gray; J M Inglis; J S Conn; G E Bath; J Gillon; D B McClelland
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

6.  Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base.

Authors:  S Franceschi; U Tirelli; E Vaccher; D Serraino; R Sorio; A Carbone; S Monfardini
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

7.  Regional variations in HIV antibody seropositivity in British intravenous drug users.

Authors:  J R Robertson; A B Bucknall; P Wiggins
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

8.  Prevalence of anti-HTLV-III in UK risk groups 1984/85.

Authors:  W J Jesson; R W Thorp; P P Mortimer; J K Oates
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

9.  HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.

Authors:  E A Follett; A McIntyre; B O'Donnell; G B Clements; U Desselberger
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

10.  Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers.

Authors:  G B Scott; M A Fischl; N Klimas; M A Fletcher; G M Dickinson; R S Levine; W P Parks
Journal:  JAMA       Date:  1985-01-18       Impact factor: 56.272

View more
  15 in total

1.  London general practitioners' involvement with HIV infection.

Authors:  M B King
Journal:  J R Coll Gen Pract       Date:  1989-07

2.  First use of heroin: changes in route of administration over time.

Authors:  J Strang; P Griffiths; B Powis; M Gossop
Journal:  BMJ       Date:  1992-05-09

Review 3.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 4.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

5.  The health of the nation: responses. Injecting drug misuse.

Authors:  J Strang
Journal:  BMJ       Date:  1991-10-26

6.  Vertical transmission of HIV: a prospective study.

Authors:  J Y Mok; R A Hague; P L Yap; F D Hargreaves; J M Inglis; J M Whitelaw; C M Steel; O B Eden; S Rebus; J F Peutherer
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

7.  Caring for intravenous drug abusers with HIV infection: some lessons from Edinburgh.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1988-08       Impact factor: 2.401

8.  Human immunodeficiency virus infection in a Dublin general practice.

Authors:  G Bury; F O'Kelly
Journal:  J R Coll Gen Pract       Date:  1989-03

9.  Human immunodeficiency virus in drug misusers and increased consultation in general practice.

Authors:  J J Roberts; C A Skidmore; J R Robertson
Journal:  J R Coll Gen Pract       Date:  1989-09

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.